Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A9 | P48067 | 10/20 | 0.44 |
| ▸ | PPARG | P37231 | 2/20 | 0.41 |
| ▸ | PPARA | Q07869 | 2/20 | 0.41 |
| ▸ | PPARD | Q03181 | 1/20 | 0.41 |
| ▸ | ESR1 | P03372 | 1/20 | 0.41 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.41 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.40 |
| ▸ | RARA | P10276 | 3/20 | 0.40 |
| ▸ | RARB | P10826 | 3/20 | 0.40 |
| ▸ | RARG | P13631 | 3/20 | 0.40 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.39 |
| ▸ | HTR7 | P34969 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29609097 | 1.00 | SLC6A9 (0.44) | SLC6A9PPARGPPARAPPARDESR1 | |
| SCHEMBL29609205 | 0.90 | SLC6A9 (0.41) | SLC6A9PPARGPPARAPPARDESR1 | |
| SCHEMBL22187695 | 0.90 | SLC6A9 (0.41) | SLC6A9PPARGPPARAPPARDESR1 | |
| SCHEMBL22187717 | 0.90 | ESR1 (0.39) | SLC6A9PPARGPPARAPPARDESR1 | |
| SCHEMBL22187732 | 0.89 | SLC6A9 (0.49) | SLC6A9RARARARBRARGHTR7 | |
| SCHEMBL29608012 | 0.89 | SLC6A9 (0.49) | SLC6A9RARARARBRARGHTR7 | |
| SCHEMBL346226 | 0.86 | ESR1 (0.56) | PPARGPPARAPPARDESR1ESR2 | |
| SCHEMBL29385692 | 0.86 | ESR1 (0.56) | PPARGPPARAPPARDESR1ESR2 | |
| SCHEMBL30314588 | 0.86 | ESR1 (0.56) | PPARGPPARAPPARDESR1ESR2 | |
| SCHEMBL22187644 | 0.84 | SLC6A9 (0.41) | SLC6A9PPARGPPARAPPARDESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3677614-B1 | THERMOPLASTIC RESIN AND OPTICAL MEMBER | TEIJIN LTD (JP) | 2026-05-27 | — | — | EP | disclosed |
| US-12441880-B2 | Poly(ester)carbonate and method for producing poly(ester)carbonate | TEIJIN LIMITED (JP) | 2025-10-14 | — | — | US | disclosed |
| EP-3733734-B1 | POLY(ESTER)CARBONATE AND METHOD FOR PRODUCING POLY(ESTER)CARBONATE | TEIJIN LTD (JP) | 2024-03-06 | — | — | EP | disclosed |
| US-20230051676-A1 | POLYCARBONATE AND METHOD FOR PRODUCING POLYCARBONATE | TEIJIN LIMITED (JP) | 2023-02-16 | — | — | US | disclosed |
| US-11505698-B2 | Polyester carbonate and method for producing polyester carbonate | TEIJIN LIMITED (JP) | 2022-11-22 | — | — | US | disclosed |
| US-11339249-B2 | Compound having fluorene skeleton, and method for manufacturing same | TEIJIN LIMITED (JP) | 2022-05-24 | — | — | US | disclosed |
| US-11261294-B2 | Thermoplastic resin and optical member | TEIJIN LIMITED (JP) | 2022-03-01 | — | — | US | disclosed |
| US-20210371650-A1 | POLY(ESTER)CARBONATE AND METHOD FOR PRODUCING POLY(ESTER)CARBONATE | TEIJIN LIMITED (JP) | 2021-12-02 | — | — | US | disclosed |
| US-20210147621-A1 | THERMOPLASTIC RESIN AND OPTICAL MEMBER | TEIJIN LIMITED (JP) | 2021-05-20 | — | — | US | disclosed |
| CN-112175178-A | Polycarbonate and preparation method and application thereof | 万华化学集团股份有限公司 | 2021-01-05 | — | — | CN | disclosed |
| EP-3747856-A1 | COMPOUND HAVING FLUORENE SKELETON, AND METHOD FOR MANUFACTURING SAME | Teijin Limited (JP) | 2020-12-09 | — | — | EP | disclosed |
| US-20200354517-A1 | COMPOUND HAVING FLUORENE SKELETON, AND METHOD FOR MANUFACTURING SAME | TEIJIN LIMITED (JP) | 2020-11-12 | — | — | US | disclosed |
| EP-3733734-A1 | POLY(ESTER)CARBONATE AND METHOD FOR PRODUCING POLY(ESTER)CARBONATE | Teijin Limited (JP) | 2020-11-04 | — | — | EP | disclosed |
| EP-3677614-A1 | THERMOPLASTIC RESIN AND OPTICAL MEMBER | Teijin Limited (JP) | 2020-07-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200354517-A1 | COMPOUND HAVING FLUORENE SKELETON, AND METHOD FOR MANUFACTURING SAME | RFT1, AFF1, RER1 | SLC6A9 4638/4885PPARG 2369/4885PPARA 1428/4885 |
| US-11339249-B2 | Compound having fluorene skeleton, and method for manufacturing same | RFT1, AFF1, RER1 | SLC6A9 4638/4885PPARG 2369/4885PPARA 1428/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.